Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Other Non-Current Assets (2016 - 2025)

Dare Bioscience's Other Non-Current Assets history spans 11 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 9.11% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, down 9.11%, while the annual FY2025 figure was $1.0 million, 9.11% down from the prior year.
  • Other Non-Current Assets reached $1.0 million in Q4 2025 per DARE's latest filing, down from $1.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.3 million in Q1 2022 to a low of $10502.0 in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $804029.6, with a median of $797881.0 recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: plummeted 97.84% in 2022, then soared 5609.33% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $485120.0 in 2021, then tumbled by 97.84% to $10502.0 in 2022, then skyrocketed by 5609.33% to $599594.0 in 2023, then surged by 85.22% to $1.1 million in 2024, then dropped by 9.11% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Other Non-Current Assets are $1.0 million (Q4 2025), $1.0 million (Q3 2025), and $1.1 million (Q2 2025).